News Focus
News Focus
Followers 843
Posts 122799
Boards Moderated 10
Alias Born 09/05/2002

Re: None

Friday, 10/05/2007 1:53:42 AM

Friday, October 05, 2007 1:53:42 AM

Post# of 3757
A three-minute portion of GILD’s UBS webcast (starting at 19:00) is worth hearing for the discussion of the HBV market. It was noted that e- patients with no evidence of abnormal liver enzymes and no cirrhosis are nonetheless at great risk for liver cancer, and this represents one of the major untapped patient pools for HBV treatment.

http://events.streamx.us/us/Event/PresentationList.aspx?id=46

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”